64
Research Trials
29
Peer-reviewed publications
17
Clinical Conditions

Updated interim data from 54 COPD patients and 135,000 monitored hours, showing cough rates rise in the days before exacerbations and correlate only weakly with CAT scores.

A month of continuous monitoring in stable chronic cough shows that multi-day averaging makes cough frequency a more reliable trial endpoint, allowing smaller studies, and reveals a short-lived Hawthorne effect.

Mixed-methods study in Kampala assessing 48-hour cough frequency monitoring with the Hyfe Research app for TB screening and triage, alongside staff-reported implementation barriers.
1 March 2023 · The International Journal of Tuberculosis and Lung Disease

This paper focuses on the potential of using cough frequency as a biomarker for tuberculosis (TB) diagnosis and monitoring treatment response. The study underscores the significance of continuous cough monitoring as a non-invasive method, which could aid in reducing overtreatment in individuals without TB and improve detection in cases missed by standard symptom-based screenings. This approach represents a significant advance in TB management, offering a more precise and patient-friendly diagnostic tool.
The study also highlights the possibility of reducing overtreatment in individuals who do not have TB and emphasizes the importance of innovative digital biomarkers in enhancing TB management, offering a more precise and patient-friendly diagnostic tool.
Bring objective cough data to your study. Schedule a meeting →